Application | Comment | Organism |
---|---|---|
drug development | the enzyme is a target for design of specific inhibitors | Clostridium botulinum |
additional information | the enzyme is used as a biowapon | Clostridium botulinum |
Crystallization (Comment) | Organism |
---|---|
purified recombinant enzyme free or in complex with substrate analogue inhibitor peptides, sitting drop vapor diffusion method at room temperature, 0.002 ml of 20 mg/ml enzyme in 2 mM DTT, 200 mM NaCl, and 20 mM HEPES, pH 7.4, is mixed with 0.002 ml reservoir solution containing 15% w/v PEG 3350, 0.3 M ammonium sulfate and 100 mM Bis-Tris buffer, pH 6.8 , equilibration against 0.8 ml of reservoir solution, plate-like crystals within a week, recombinant Balc424 is co-crystallized individually with the tetrapeptides, sitting drop vapor diffusion method at room temperature using conditions similar to native protein, Balc424 gives good complex crystals with RRGC, RRGM, RRGL and RRGI at stoichiometric ratios of 1:30, 1:30, 1:40 and 1:40, respectively, X-ray diffraction structure determination and analysis at 1.6-1.8 A resolution | Clostridium botulinum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
RRGC | an inhibitory substrate analogue tetrapeptide, binding structure, overview | Clostridium botulinum | |
RRGI | an inhibitory substrate analogue tetrapeptide, binding structure, overview | Clostridium botulinum | |
RRGL | an inhibitory substrate analogue tetrapeptide, binding structure, overview | Clostridium botulinum | |
RRGM | an inhibitory substrate analogue tetrapeptide, binding structure, overview | Clostridium botulinum |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Clostridium botulinum | the seven antigenically distinct serotypes of Clostridium botulinum neurotoxins cleave specific SNARE complex proteins and block the release of neurotransmitters causing flaccid paralysis and are considered potential bioweapons, botulinum neurotoxin type A is the most potent among the clostridial neurotoxins | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Clostridium botulinum | P10845 | seven antigenically distinct serotypes of neurotoxins | - |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
Limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevin (also known as neuronal vesicle-associated membrane protein, VAMP), synaptosome-associated protein of 25 kDa (SNAP25) or syntaxin. No detected action on small molecule substrates | enzyme-substrate interaction at the active site, Tyr366 and Arg363 are important for catalysis, the S1' site is formed by Phe194, Thr215, Thr220, Asp370, and Arg363, reaction mechanism, overview | Clostridium botulinum |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | the seven antigenically distinct serotypes of Clostridium botulinum neurotoxins cleave specific SNARE complex proteins and block the release of neurotransmitters causing flaccid paralysis and are considered potential bioweapons, botulinum neurotoxin type A is the most potent among the clostridial neurotoxins | Clostridium botulinum | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Balc424 | - |
Clostridium botulinum |
botulinum neurotoxin type A | - |
Clostridium botulinum |
Clostridium botulinum neurotoxin serotype A | - |
Clostridium botulinum |